Home / Jamjoom Pharmaceuticals Factory Co. / 2020 Annual Results

Jamjoom Pharmaceuticals Factory Co. 2020 Annual Results

Revenue

SAR 292M

Net Profit

SAR 207M

Jamjoom Pharmaceuticals Factory Co. (4015) reported full year 2020 revenue of SAR 292M, down 5.6% from SAR 309M in 2019. Net profit came in at SAR 207M, up 31.8% year on year. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Key Financial Metrics

Metric	2020	2019
Revenue	SAR 292M	SAR 309M
Net Profit	SAR 207M	SAR 157M
Gross Profit	SAR 513M	SAR 422M
Net Margin	70.8%	50.7%
ROE	17.5%	14.7%
Total Assets	SAR 1.50B	SAR 1.28B
Total Equity	SAR 1.18B	SAR 1.07B

Year on Year Comparison

Revenue decreased by 5.6% compared to 2019. Net profit increased by 31.8%. Revenue declined but profit grew — indicating improved efficiency or cost control.

View full company profile →

View all years:

2025 2024 2023 2022 2021 2020 2019

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2023-06-21.